R

Active Director Director DIN 09141984
DIN 09141984 First appointment Apr 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value •••• Premium profile

About Refaya

Data last updated:

Refaya is a Director at Cytokine Healthcare Private Limited (since 2021). The company operates in Chemicals. Cytokine Healthcare Private Limited reported revenue of ₹65.9 Lakh (FY 2025).

DIN 09141984
Primary Designation Director
Industry Chemicals
First Appointment 12 Apr 2021
Oldest Company Age 5 yrs
Largest company Cytokine Healthcare Private Limited · ₹65.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cytokine Healthcare Private Limited U24239TN2021PTC142712
Director12 Apr 20212021₹65.9 Lakh (FY 2025)Active

Board colleagues of Refaya

NameDINCompanyDesignation
Nasrudeen09141983Cytokine Healthcare Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Cytokine Healthcare Private Limited
Premium access

Shareholding and investment profile for Refaya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Refaya

Refaya currently holds 1 directorship: Cytokine Healthcare Private Limited (Director, since 12 Apr 2021, revenue ₹65.9 Lakh (FY 2025)).

Refaya was first appointed on 12 Apr 2021 as Director at Cytokine Healthcare Private Limited.

The current boards of Refaya's companies include Nasrudeen (Cytokine Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available